Reversible Cerebral Vasoconstriction Syndrome clinical trials

Explore recruiting reversible cerebral vasoconstriction syndrome clinical trials.

Also recruiting in Europe

Reversible Cerebral Vasoconstriction Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Calcium Channel blocker in treatment of reversible cerebral vasoconstriction syndrome: a double-blind, randomized, placebo-controlled trial.

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Reversible Cerebral Vasoconstriction Syndrome trials by city

Reversible Cerebral Vasoconstriction Syndrome in Toronto Reversible Cerebral Vasoconstriction Syndrome in Vancouver Reversible Cerebral Vasoconstriction Syndrome in Montreal Reversible Cerebral Vasoconstriction Syndrome in Calgary Reversible Cerebral Vasoconstriction Syndrome in Edmonton Reversible Cerebral Vasoconstriction Syndrome in Ottawa Reversible Cerebral Vasoconstriction Syndrome in Winnipeg Reversible Cerebral Vasoconstriction Syndrome in Quebec City Reversible Cerebral Vasoconstriction Syndrome in Hamilton Reversible Cerebral Vasoconstriction Syndrome in Kitchener Reversible Cerebral Vasoconstriction Syndrome in London Reversible Cerebral Vasoconstriction Syndrome in Halifax Reversible Cerebral Vasoconstriction Syndrome in New York Reversible Cerebral Vasoconstriction Syndrome in Los Angeles Reversible Cerebral Vasoconstriction Syndrome in Chicago Reversible Cerebral Vasoconstriction Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease